Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1629267596
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
240 W Thomas Rd, Suite 301
Phoenix, AZ, 85013
Phone (602) 406-6262
Groups this clinician bills Medicare through
Medicare paid, 2024
$546K
75,206 services
Medicare patients, 2024
373
Average age 74
Drug cost, 2024
$3.6M
6,340 prescriptions
Company payments, 2025
$91.96
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Guillermo Moguel-Cobos was code J0585 (injection, onabotulinumtoxina, 1 unit), 63,351 times for 90 patients. In total Guillermo Moguel-Cobos billed 75,206 services in 34 codes, and Medicare paid $546K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-04.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 63,351 | 90 | $4.89 | $310K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 6,951 | 13 | $4.10 | $28K |
| 99214 Office E&M - Established | Office | 344 | 205 | $93.03 | $32K |
| 64616 Musculoskeletal | Office | 152 | 51 | $135.95 | $21K |
| 64612 Musculoskeletal | Office | 130 | 45 | $111.42 | $14K |
| 95983 Electrical Nerve Conductivity | Office | 103 | 41 | $35.09 | $3,614 |
| 99215 Office E&M - Established | Office | 103 | 79 | $133.87 | $14K |
| 95874 Musculoskeletal | Office | 101 | 32 | $56.20 | $5,676 |
| 99213 Office E&M - Established | Office | 74 | 57 | $59.19 | $4,380 |
| 64642 Musculoskeletal | Office | 68 | 31 | $76.47 | $5,200 |
| 64643 Musculoskeletal | Office | 58 | 21 | $69.30 | $4,020 |
| 64646 Musculoskeletal | Office | 56 | 22 | $72.69 | $4,071 |
| 99205 Office E&M - New | Office | 50 | 50 | $163.64 | $8,182 |
| 64644 Musculoskeletal | Office | 46 | 14 | $124.73 | $5,738 |
| 95984 Electrical Nerve Conductivity | Office | 26 | 12 | $29.14 | $758 |
By year: 2022 $505K for 77,417 services; 2023 $540K for 81,230 services; 2024 $546K for 75,206 services.
Medicare prescription drug claims, 2024
In 2024, the drug Guillermo Moguel-Cobos prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 669 prescriptions and refills. In total Guillermo Moguel-Cobos wrote 6,340 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 669 | 1,413 | 185 | $23K |
| Amantadine Amantadine Hcl | 492 | 910 | 124 | $41K |
| Clonazepam Generic | 381 | 522 | 71 | $4,610 |
| Memantine Hcl Generic | 264 | 448 | 60 | $6,608 |
| Donepezil Hcl Generic | 210 | 409 | 42 | $2,236 |
| Quetiapine Fumarate Generic | 201 | 346 | 44 | $2,578 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 198 | 426 | 58 | $8,839 |
| Baclofen Generic | 174 | 341 | 45 | $4,102 |
| Rytary Carbidopa/Levodopa | 171 | 259 | 39 | $349K |
| Gabapentin Generic | 167 | 332 | 42 | $4,367 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 155 | 334 | 43 | $4,209 |
| Pyridostigmine Bromide Generic | 124 | 180 | 24 | $6,133 |
| Ingrezza Valbenazine Tosylate | 121 | 121 | 12 | $1.0M |
| Nuplazid Pimavanserin Tartrate | 117 | 135 | 19 | $653K |
| Primidone Generic | 111 | 250 | 25 | $2,823 |
Brand drugs: 915 claims; generic drugs: 5,425 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Guillermo Moguel-Cobos $91.96 ($91.96 in general payments such as food, travel and fees) from 1 company. The largest payer was Teva Pharmaceuticals USA, Inc. with $91.96.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $91.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.